The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | 13,290 | 598,385 | SH | SOLE | 598,385 | 0 | 0 | |||
89BIO INC | COM | 282559103 | 9,652 | 758,244 | SH | SOLE | 758,244 | 0 | 0 | |||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 29,615 | 1,880,286 | SH | SOLE | 1,880,286 | 0 | 0 | |||
ACUMEN PHARMACEUTICALS INC | COM | 00509G209 | 2,691 | 498,315 | SH | SOLE | 498,315 | 0 | 0 | |||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 29,432 | 537,076 | SH | SOLE | 537,076 | 0 | 0 | |||
ALLAKOS INC | COM | 01671P100 | 13,838 | 1,643,500 | SH | SOLE | 1,643,500 | 0 | 0 | |||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 9,739 | 1,325,000 | SH | SOLE | 1,325,000 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 18,323 | 591,437 | SH | SOLE | 591,437 | 0 | 0 | |||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 18,743 | 462,111 | SH | SOLE | 462,111 | 0 | 0 | |||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 13,108 | 590,705 | SH | SOLE | 590,705 | 0 | 0 | |||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 43,595 | 5,303,557 | SH | SOLE | 5,303,557 | 0 | 0 | |||
CABALETTA BIO INC | COM | 12674W109 | 9,346 | 1,010,359 | SH | SOLE | 1,010,359 | 0 | 0 | |||
CELCUITY INC | COM | 15102K100 | 18,605 | 1,327,952 | SH | SOLE | 1,327,952 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 22,099 | 495,823 | SH | SOLE | 495,823 | 0 | 0 | |||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 49,939 | 4,319,940 | SH | SOLE | 4,319,940 | 0 | 0 | |||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 35,980 | 5,738,500 | SH | SOLE | 5,738,500 | 0 | 0 | |||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 15,918 | 739,661 | SH | SOLE | 739,661 | 0 | 0 | |||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 142 | 92,687 | SH | SOLE | 92,687 | 0 | 0 | |||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 10,397 | 223,494 | SH | SOLE | 223,494 | 0 | 0 | |||
IMARA INC | COM | 45249V107 | 10,204 | 2,494,794 | SH | SOLE | 2,494,794 | 0 | 0 | |||
IMMUNIC INC | COM | 4525EP101 | 2,520 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 20,421 | 1,150,505 | SH | SOLE | 1,150,505 | 0 | 0 | |||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 2,113 | 312,553 | SH | SOLE | 312,553 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 6,581 | 1,935,609 | SH | SOLE | 1,935,609 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 13,644 | 1,099,407 | SH | SOLE | 1,099,407 | 0 | 0 | |||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 3,098 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | |||
MERUS N V | COM | N5749R100 | 42,273 | 2,732,567 | SH | SOLE | 2,732,567 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 27,208 | 913,621 | SH | SOLE | 913,621 | 0 | 0 | |||
PROMETHEUS BIOSCIENCES INC | COM | 74349U108 | 13,987 | 127,156 | SH | SOLE | 127,156 | 0 | 0 | |||
REZOLUTE INC | COM NEW | 76200L309 | 2,505 | 1,210,000 | SH | SOLE | 1,210,000 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 17,521 | 688,445 | SH | SOLE | 688,445 | 0 | 0 | |||
THIRD HARMONIC BIO INC | COM | 88427A107 | 4,271 | 993,294 | SH | SOLE | 993,294 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 8,318 | 173,481 | SH | SOLE | 173,481 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 59,009 | 2,020,166 | SH | SOLE | 2,020,166 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 65,419 | 1,659,111 | SH | SOLE | 1,659,111 | 0 | 0 |